The President of the Republic Francisco Sagasti on Wednesday announced that the purchase of the first batch of vaccines against coronavirus (COVID-19) from the
Chinese laboratory Sinopharm has been completed, adding that the first shipment will arrive this January.
"After long, complex, and tough negotiations that seemed frustrating at times, I can announce that we have completed the purchase of the first batch of the long-awaited vaccines against the pandemic," he said in a televised address to the nation from the Government Palace.
Sinopharm
Within the framework of the purchase agreement for 38 million doses, the Head of State reported that a purchase agreement and commitment letter have been signed to receive a first shipment (one million doses) this January.
According to the statesman, between 14 and 15 million Peruvian citizens are expected to be vaccinated before the winter season starts in the country (in June).
AstraZeneca
Likewise, the President said that a purchase agreement with AstraZeneca has been signed today.
It will serve to deliver 14 million doses of the vaccine starting September this year, although steps are being taken to advance the shipments.
COVAX Facility
Moreover, the top official mentioned that there is a preliminary agreement with the
COVAX Facility, which will
deliver 13.2 million doses on a date yet to be set, because this depends on an international agreement between COVAX and the suppliers.
"These vaccines are scheduled to arrive in the third quarter (of 2021)," he forecast.
The Peruvian leader also mentioned that active negotiations are being conducted with laboratories in the United States, Germany, Russia, and India, in order to ensure that all Peruvians are protected before the end of the current year.
In addition, the Peruvian vaccine developed by Cayetano Heredia University and pharmaceutical company Farvet is being closely monitored by the Government, he concluded.
(END) VVS/MVB
Published: 1/6/2021